← Eichor
Study identifier: NCT03675412 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Caffeine Consumption in Glaucoma Patients and Healthy Subjects

Condition: Glaucoma, Primary Open Angle  ·  Sponsor: Wills Eye

PhaseNA
Planned participants80
Who can joinAll sexes, 18 Years to 90 Years
Healthy volunteersYes

About this study

Caffeine is the most widely consumed drinking nutrient in the world. Caffeine effects various organs and the vascular system. It decreases ocular blood flow due to vasoconstriction.

This description comes directly from the study's public registry record.

Talk to the study team

M. Reza Razeghinejad, MD  ·  215-928-7023  ·  mrazeghi@willseye.org

Jeanne Molineaux, COA  ·  215-825-4713  ·  jmolineaux@gwillseye.org

Always discuss trial participation with your own doctor first.

Locations (1)

Wills Eye Glaucoma ServicePhiladelphia, Pennsylvania, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT03675412